CITIC M&A Fund, Legend Capital Lead $280M Investment In Pharmaron

Login to View

CITIC M&A Fund and Legend Capital have agreed to lead an investor consortium to invest US$280 million in Pharmaron, a contract research organization (CRO) for the pharmaceutical industry, according to an announcement.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in